DIRC3 is a MITF-repressed lncRNA that blocks the anchorage-independent growth of melanoma cells whilst the MITF activated lncRNA LENOX promotes melanoma cell survival and resistance to MAP kinase inhibitors [22,23]. Here, MITF is linked to melanoma.